Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1641 1642 1644 1645 1658 1671
This examiner grants 59% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18553523 | CLASSIFICATION OF NEUROLOGICAL OR PSYCHIATRIC DISEASE MANIFESTATIONS USING MULTI-DIMENSIONAL CEREBROSPINAL FLUID ANALYSIS | Non-Final OA | The Regents of the University of California |
| 18271540 | Personalized Longitudinal Analysis of Circulating Material to Monitor and Adapt Neoantigen Cancer Vaccines | Final Rejection | AMAZON TECHNOLOGIES, INC. |
| 18286903 | Digital Protein Misfolding Assays | Non-Final OA | President and Fellows of Harvard College |
| 18512522 | MODULATING BONE MORPHOGENIC PROTEIN (BMP) SIGNALING IN THE TREATMENT OF ALZHEIMER'S DISEASE | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18550537 | METHODS FOR TREATING CANCER WITH ANTI-ILT3 ANTIBODIES | Non-Final OA | Merck Sharp & Dohme LLC |
| 16863800 | METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-33 ANTAGONIST | Final Rejection | REGENERON PHARMACEUTICALS, INC. |
| 17907039 | CORONA NUCLEOCAPSID ANTIGEN FOR USE IN ANTIBODY-IMMUNOASSAYS | Final Rejection | Roche Diagnostics Operations, Inc. |
| 18146014 | COMBINATION OF AN ANTI-PD-L1 ANTIBODY AND A DNA-PK INHIBITOR FOR THE TREATMENT OF CANCER | Non-Final OA | Pfizer Inc. |
| 18223730 | COMPOSITIONS AND METHODS FOR TREATING A DISEASE | Final Rejection | RAMOT AT TEL AVIV UNIVERSITY LTD. |
| 18285125 | MAGEB2 BINDING CONSTRUCTS | Non-Final OA | Amgen Inc. |
| 17641044 | TREATMENT METHODS FOR EYE DISORDERS | Final Rejection | University of Pittsburgh - of the Commonwealth System of Higher Education |
| 18554176 | METHODS FOR INHIBITING KRAS ONCOPROTEIN THROUGH ENHANCED GTPASE ACTIVITY | Non-Final OA | Sloan-Kettering Institute for Cancer Research |
| 18288420 | Mesothelin-specific T cell Receptors and Methods of Using Same | Non-Final OA | FRED HUTCHINSON CANCER CENTER |
| 18506518 | ANTIGEN-BINDING PROTEINS TARGETING MELANOMA DIFFERENTIATION ANTIGENS AND USES THEREOF | Non-Final OA | MEMORIAL SLOAN-KETTERING CANCER CENTER |
| 17622375 | A PEPTIDE-BASED SCREENING METHOD TO IDENTIFY NEOANTIGENS FOR USE WITH TUMOR INFILTRATING LYMPHOCYTES | Non-Final OA | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. |
| 17757383 | SUPPRESSION OF INTERLEUKIN-17 PRODUCTION AND INHIBITION OF TH17 CELL GENERATION BY FIBROBLASTS AND PRODUCTS THEREOF | Final Rejection | FIGENE, LLC |
| 18551356 | METHODS AND COMPOUNDS FOR NEOANTIGEN VACCINES | Non-Final OA | THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE |
| 17059516 | HSP70 PROTEIN LEVELS IN PBMC SAMPLES AS BIOMARKER FOR DISEASE | Non-Final OA | Zevra Denmark A/S |
| 18007978 | Compositions and Methods for the Treatment of Synucleinopathies | Final Rejection | SOLA BIOSCIENCES LLC |
| 16604484 | GENE THERAPY | Non-Final OA | Fondazione Telethon |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy